MedBiome

We are delighted to share our new paper just online in NatComm @NatureComms. Microbiome studies often relates diversity to health and disease. In our gut, while diversity matters, we show that functional redundancy (FR) may count more. A thread (1/9) nature.com/articles/s4146…

CNPN is partnering with HUPO to offer two travel awards to attend HUPO 2023 in Busan, Korea.  The award includes complementary registration from HUPO and $500 CDN for travel expenses. Deadline: June 14. cnpn.ca/hupo-travel-aw…

MedBiome presented today it's transformative precision microbiome nutrition approach at #FTC2023 in Warsaw.

I'm excited to share that we are the finalists at the Food Tech Congress 2023 startup pitch competition! To learn more click here: foodtechchallengers.com #FTC2023

I'm excited to share that we are the finalists at the Food Tech Congress 2023 startup pitch competition! To learn more click here: foodtechchallengers.com #FTC2023

Interested in TMT for #proteomics and #metaproteomics but have limited budget? See the new dry TMT approach by in BiorXiv. @Xu_Zhang1 biorxiv.org/cgi/content/sh…

Interested in the effects of xenobiotics on microbiomes? Check out the RapidAIM 2.0 assay to study composition and functional responses of individual human gut #microbiome to #xenobiotics. @NorthOmics @li_leyuan

iMetaLab includes (1) MetaLab Desktop, facilities proteins identification and quantitation from microbiomes; (2) iMetaReport, access database search results and data set profiles; and (3) iMetaShiny, cover functional, taxonomic, and statistical analysis. onlinelibrary.wiley.com/doi/10.1002/im…

Do you use sugar substitutes? Wonder if they affect your gut #microbiome? See the article by Zhongzhi Sun et al. who systematically investigated the responses of human gut microbiomes to 21 common sugar substitute sweeteners. @NorthOmics @PharmdU @ ow.ly/l66050Jw3lW

👀👀👀! @CNPN_org #CNPN2022

Dr. Mayne @JaniceEMayne et al. report, with @Proteonpharma and @BiomeMed, that healthy ex-vivo human gut #microbiota composition and function are unaffected by BAFASAL®(bacteriophage cocktail targeting Salmonella). Amazing collaboration. @uOttawaMed mdpi.com/1999-4915/13/9…

MedBiome with Proteon Pharmaceutical @Proteonpharma and the University of Ottawa @uOttawa report on the effect of an anti-salmonella bacteriophage on individual human gut microbiomes using the RapidAIM technology. ow.ly/eVkJ50FpZjj

MedBiome is pleased to announce that it will attend the digital China Bio Partnering Forum on Aug 25-27 2020. Looking forward to new partnerships. MedBiome develops Precision Microbiome Therapeutics and Nutrition. informaconnect.com/chinabio-partn…

MEET THE COMPANY ⚡️@scale_up_garage 2020 @BiomeMed seeks to develop a system to very accurately culture the human microbiome in specialized conditions to accurately represent what’s happening in our own gut. Find out more >> bit.ly/2Cok0cq

RENCONTREZ L'ENTREPRISE ⚡️ @scale_up_garage 2020 @BiomeMed cherche à concevoir un système qui cultiverait avec grande précision le microbiome humain dans des conditions spécialisées afin de représenter ce qui se passe exactement dans l’intestin. bit.ly/3fOm6Rn

MedBiome's founders demonstrated, using 17 berberine analogs, that subsets of compounds have distinct effects on individual #gut #microbiome. ow.ly/23ni50zyqVJ The study was performed using our RapidAIM live microbiome assay. medbiome.ca

Did you know that #drugs can affect bacterial functions in the gut #microbiome without changing their abundances? Only looking at microbiome composition is insufficient to understand whether drugs have functional effects on the microbiome. More details: rdcu.be/b2Q7r

Should drugs, natural compounds, food additives, pesticides and other compounds be tested for effects on the human gut #microbiome ? We now have the in vitro technology, called RapidAIM, to do the testing. See publication in Microbiome rdcu.be/b2Q7r @BioMedCentral

Interested in testing drugs and compounds for their effects on human microbiome? See the latest paper on MedBiome's RapidAIM technology.

MedBiome announces the licensing of MetaLab from @uOttawa @uOttawaMed. MetaLab(imetalab.ca) is a leading software for #metaproteomics. MedBiome develops Precision Microbiome Therapeutics for #IBD and other diseases. medbiome.ca #microbiome